Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
27.03.25
/
50%
€36.00
Target price
27.03.26
€108.68
Performance (%)
-22.22%
Price
07:36
?
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -22.22%. This prediction currently runs until 27.03.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.895% | -7.895% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at JPMorgan Chase & Co. from $104.00 to $117.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.00
21.11.24
21.11.24
€96.83
21.11.25
21.11.25
-34.09%
22.11.25
22.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€81.12
27.02.25
27.02.25
-17.74%
28.02.25
28.02.25